Edition:
India

Harbin Pharmaceutical Group Co Ltd (600664.SS)

600664.SS on Shanghai Stock Exchange

4.93CNY
23 May 2018
Change (% chg)

¥-0.08 (-1.60%)
Prev Close
¥5.01
Open
¥5.01
Day's High
¥5.01
Day's Low
¥4.91
Volume
15,107,307
Avg. Vol
22,517,981
52-wk High
¥6.06
52-wk Low
¥4.83

Chart for

About

HARBIN PHARMACEUTICAL GROUP CO., LTD. is a China-based company, principally engaged in the manufacture and distribution of pharmaceuticals. The Company's major products include chemical raw medicines, antibiotics, Chinese medicines, chemical drugs, over-the-counter (OTC) medicines, healthcare products, biological engineering,... (more)

Overall

Beta: 0.76
Market Cap(Mil.): ¥14,764.62
Shares Outstanding(Mil.): 2,541.24
Dividend: 0.50
Yield (%): 8.61

Financials

  600664.SS Industry Sector
P/E (TTM): 19.64 30.95 32.75
EPS (TTM): 0.30 -- --
ROI: 10.39 14.84 14.38
ROE: 10.54 16.34 16.07

China's Harbin Pharma to buy stake in U.S. health retailer GNC

HONG KONG China's state-controlled drugmaker Harbin Pharmaceutical Group Holding Co will buy an about 40 percent stake in U.S. nutritional supplements retailer GNC Holdings Inc for $300 million and are in talks for a joint venture in China, the companies said.

14 Feb 2018

China's Harbin Pharma to buy stake in U.S. health retailer GNC

HONG KONG, Feb 14 China's state-controlled drugmaker Harbin Pharmaceutical Group Holding Co will buy an about 40 percent stake in U.S. nutritional supplements retailer GNC Holdings Inc for $300 million and are in talks for a joint venture in China, the companies said.

14 Feb 2018

BRIEF-GNC Holdings Says On Deal Termination Co to Pay Termination Fee Of Either $10 Mln Or $18 Mln To Harbin Pharmaceutical

* GNC HOLDINGS - ON DEAL TERMINATION UNDER CIRCUMSTANCES, CO WILL PAY FEE OF EITHER $10 MILLION OR $18 MILLION TO HARBIN PHARMACEUTICAL GROUP - SEC FILING Source text: (http://bit.ly/2o4g6KY) Further company coverage:

14 Feb 2018

Earnings vs. Estimates